drugset / Trial / NCT03923010

A Study of Itraconazole in the Management of Superficial Fungal Infections in India

NCT03923010

Phase 4 Terminated 40 enrolled Janssen Research & Development, LLC
NaSingle-groupOpen-labelPrevention

Summary

The purpose of this study is to estimate the proportion of participants prescribed itraconazole for Tinea cruris or Tinea corporis who have clinical response after 7 days of treatment.

Timeline

Start
2019-08-06
Primary completion
2020-03-25
Completion
2020-03-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule 200 mg Oral